Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Patrick P, Strunz"'
Autor:
Marc Schmalzing, Michael Gernert, Matthias Fröhlich, Jörg Henes, Nathalie Schwindl, Leona Zerhusen, Lukas Berthold, Johannes Hewig, Andrea Kübler, Ann-Christin Pecher, Sonja Kleih-Dahms, Patrick-Pascal Strunz, Philipp Ziebell
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveIn severe cases of systemic sclerosis (SSc), autologous hematopoietic stem cell transplantation (aHSCT) is superior compared to cyclophosphamide. But treatment related morbidity and mortality have to be considered. To date, data on major phy
Externí odkaz:
https://doaj.org/article/506753c369594f61a696c031cef298a3
Autor:
Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, Torsten Witte, Matthias Froehlich, Marc Schmalzing, Michael Gernert, Sebastian Hueper, Peter Bartz-Bazzanella, Cay von der Decken, Kirsten Karberg, Georg Gauler, Susanna Späthling-Mestekemper, Christoph Kuhn, Wolfgang Vorbrüggen, Martin Welcker, Stefan Kleinert
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundSafety recommendations for Janus kinase inhibitors (JAKi) issued by the European Medical Agency (EMA) in 2023 could potentially influence treatment patterns for rheumatoid arthritis (RA) drugs, but little is known about the impact of these
Externí odkaz:
https://doaj.org/article/8fdf039605db47819e20145e68fee00c
Autor:
Patrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, Torsten Witte, Matthias Froehlich, Marc Schmalzing, Michael Gernert, Astrid Schmieder, Peter Bartz-Bazzanella, Cay von der Decken, Kirsten Karberg, Georg Gauler, Patrick Wurth, Susanna Späthling-Mestekemper, Christoph Kuhn, Wolfgang Vorbrüggen, Johannes Heck, Martin Welcker, Stefan Kleinert
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTreatment options with disease-modifying antirheumatic drugs (DMARDs) for psoriatic arthritis (PsA) have evolved over recent years. In addition to Janus kinase inhibitors (JAKi), four classes of biologic DMARDs (bDMARDs; interleukin [IL]-23
Externí odkaz:
https://doaj.org/article/d38dc92500c142f5b13b040faad3b569
Autor:
Patrick-Pascal Strunz, Hannah Labinsky, Lea-Kristin Nagler, Jan Portegys, Matthias Froehlich, Michael Gernert, Marc Schmalzing
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment option in patients with severe forms of systemic sclerosis (SSc) by resetting the immune system. Nevertheless, secondary autoimmune disorders and progressive
Externí odkaz:
https://doaj.org/article/3128700a380d40c4819806fb42761d6c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael Gernert, Marc Schmalzing, Hans-Peter Tony, Patrick-Pascal Strunz, Eva Christina Schwaneck, Matthias Fröhlich
Publikováno v:
Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-9 (2022)
Abstract Background Assessing serological inflammation is difficult in tocilizumab (TCZ)-treated rheumatoid arthritis (RA) patients, as standard inflammation parameters, like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), are infl
Externí odkaz:
https://doaj.org/article/d080d36268a74f88b3c58b8d6a8f913c
Autor:
Matthias Froehlich, Antonia Zahner, Marc Schmalzing, Michael Gernert, Patrick-Pascal Strunz, Sebastian Hueper, Jan Portegys, Eva Christina Schwaneck, Ottar Gadeholt, Andrea Kübler, Johannes Hewig, Philipp Ziebell
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectivesThe spectrum of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) represents highly inflammatory rheumatic diseases. Patients mostly report severe physical impairment. Possible consequences for mental health have been scarcely stu
Externí odkaz:
https://doaj.org/article/3abcbc0a6e2943879000aa7738db2404
Autor:
Andreas Rosenwald, Marc Schmalzing, Matthias Fröhlich, Jan Portegys, Anke Heidemeier, Michael Gernert, Sebastian Hueper, Patrick Pascal Strunz, Leo Rasche
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Erdheim-Chester disease (ECD) is a non-Langerhans cell histiocytosis characterised by clonal expansion of histiocytes in various organs. These induce an inflammatory environment, which leads to damage of the affected areas. Recently, a new disease en
Externí odkaz:
https://doaj.org/article/6a5b0638d7ff4b48a7c2029889cca1d6
Autor:
Michael Gernert, Matthias Kiesel, Matthias Fröhlich, Regina Renner, Patrick-Pascal Strunz, Jan Portegys, Hans-Peter Tony, Marc Schmalzing, Eva Christina Schwaneck
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundGenital human papillomavirus (HPV)-infections are common in the general population and are responsible for relevant numbers of epithelial malignancies. Much data on the HPV-prevalence is available for secondary immunodeficiencies, especiall
Externí odkaz:
https://doaj.org/article/73a759cc73644789bfff6eee5b467c01
Autor:
Patrick-Pascal Strunz, Matthias Froehlich, Michael Gernert, Eva Christina Schwaneck, Anna Fleischer, Ann-Christin Pecher, Hans-Peter Tony, Joerg Christoph Henes, Marc Schmalzing
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Autologous hematopoietic stem cell transplantation (aHSCT) represents an effective treatment for systemic sclerosis (SSc), but it also can cause immunological adverse events (iAEs). Therefore, we aimed to determine the frequency of iAEs [engraftment
Externí odkaz:
https://doaj.org/article/3bfbc3edfa574231bce6e9c59a4b1426